|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print July 30, 2002
Am J Physiol Renal Physiol, 10.1152/ajprenal.00059.2002
Submitted on February 11, 2002
Accepted on July 26, 2002
1 The Water and Salt Research Center, University of Aarhus, Aarhus, Denmark; Department of Physiology, Dongguk University, Kyungju, Korea, Republic of
2 The Water and Salt Research Center, University of Aarhus, Aarhus, Denmark; Laboratory of Kidney and Electrolyte Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
3 Laboratory of Kidney and Electrolyte Metabolism, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
4 The Water and Salt Research Center, University of Aarhus, Aarhus, Denmark
* To whom correspondence should be addressed. E-mail: sn{at}ana.au.dk.
Adrenocortical steroid hormones are importantly involved in the regulation of extracellular fluid volume. The present study was aimed to examine whether aldosterone and/or glucocorticoid regulates the abundance of AQP-3, -2, and -1 in rat kidney. In protocol 1, rats were adrenalectomized followed by aldosterone replacement, dexamethasone replacement, or combined aldosterone and dexamethasone replacement (rats had free access to water but received a fixed amount of food). Protocol 2 was identical to protocol 1 except all groups received fixed daily food and water intake. In both protocol 1 and 2, aldosterone deficiency was associated with increased FENa and severe hyperkalemia. Semiquantitative immunoblotting revealed that aldosterone deficiency was associated with a dramatic downregulation of AQP3 abundance. Consistent with this, immunocytochemistry and immunoelectron microscopy revealed a marked decrease of AQP3 labeling in the basolateral plasma membranes of collecting duct principal cells. In contrast, AQP1 and AQP2 abundance and distribution was unchanged. Glucocorticoid deficiency revealed no changes in AQP3, -2, or -1 abundances. In protocol 3, sodium restriction (to increase endogenous aldosterone levels) or exogenous aldosterone infusion to either Wistar rats or vasopressin-deficient Brattleboro rats was associated with a major increase in AQP3 abundance whereas no change in AQP2 abundance was seen. In protocol 4, aldosterone levels were clamped by infusion of aldosterone, while Na intake was altered from low to a high level. Under these circumstances, there were no changes in AQP3 or AQP2 abundance, although the level of the Na-Cl cotransporter was decreased. In conclusion the results uniformly demonstrate that aldosterone regulates AQP3 abundance independent of sodium intake. In contrast, changes in glucocorticoid levels in these models do not influence AQP3 or AQP2 abundance. Therefore in the collecting duct aldosterone may regulate, at least in part, AQP3 expression in addition to regulating Na+ and K+ transport.
This article has been cited by other articles:
![]() |
U. Hasler, V. Leroy, P.-Y. Martin, and E. Feraille Aquaporin-2 abundance in the renal collecting duct: new insights from cultured cell models Am J Physiol Renal Physiol, July 1, 2009; 297(1): F10 - F18. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. O'Neill, J. Lebeck, P. B. Collins, T.-H. Kwon, J. Frokiaer, and S. Nielsen Aldosterone-mediated apical targeting of ENaC subunits is blunted in rats with streptozotocin-induced diabetes mellitus Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1546 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Fenton and M. A. Knepper Mouse Models and the Urinary Concentrating Mechanism in the New Millennium Physiol Rev, October 1, 2007; 87(4): 1083 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. H. Kim, V. Pech, K. B. Spencer, W. H. Beierwaltes, L. A. Everett, E. D. Green, W. Shin, J. W. Verlander, R. L. Sutliff, and S. M. Wall Reduced ENaC protein abundance contributes to the lower blood pressure observed in pendrin-null mice Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1314 - F1324. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. de Seigneux, J. Nielsen, E. T. B. Olesen, H. Dimke, T.-H. Kwon, J. Frokiaer, and S. Nielsen Long-term aldosterone treatment induces decreased apical but increased basolateral expression of AQP2 in CCD of rat kidney Am J Physiol Renal Physiol, July 1, 2007; 293(1): F87 - F99. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Park, M.-J. Choi, I.-K. Song, S.-Y. Choi, J.-O. Nam, C.-D. Kim, B.-H. Lee, R.-W. Park, K. M. Park, Y.-J. Kim, et al. Erythropoietin Decreases Renal Fibrosis in Mice with Ureteral Obstruction: Role of Inhibiting TGF-beta-Induced Epithelial-to-Mesenchymal Transition J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1497 - 1507. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Elkareh, D. J. Kennedy, B. Yashaswi, S. Vetteth, A. Shidyak, E. G. R. Kim, S. Smaili, S. M. Periyasamy, I. M. Hariri, L. Fedorova, et al. Marinobufagenin Stimulates Fibroblast Collagen Production and Causes Fibrosis in Experimental Uremic Cardiomyopathy Hypertension, January 1, 2007; 49(1): 215 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Wang, C. Li, S. N. Summer, S. Falk, M. A. Cadnapaphornchai, Y.-C. Chen, and R. W. Schrier Molecular analysis of impaired urinary diluting capacity in glucocorticoid deficiency Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1135 - F1142. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nielsen, T.-H. Kwon, J. Praetorius, J. Frokiaer, M. A. Knepper, and S. Nielsen Aldosterone increases urine production and decreases apical AQP2 expression in rats with diabetes insipidus Am J Physiol Renal Physiol, February 1, 2006; 290(2): F438 - F449. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Makhanova, G. Lee, N. Takahashi, M. L. Sequeira Lopez, R. A. Gomez, H.-S. Kim, and O. Smithies Kidney function in mice lacking aldosterone Am J Physiol Renal Physiol, January 1, 2006; 290(1): F61 - F69. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rojek, J. Nielsen, H. L. Brooks, H. Gong, Y.-H. Kim, T.-H. Kwon, J. Frokiaer, and S. Nielsen Altered expression of selected genes in kidney of rats with lithium-induced NDI Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1276 - F1289. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Lim, C. Li, B.-K. Sun, K.-H. Han, W.-Y. Kim, Y.-W. Oh, J.-U. Lee, P. F. Kador, M. A. Knepper, J. M. Sands, et al. Long-term treatment with cyclosporine decreases aquaporins and urea transporters in the rat kidney Am J Physiol Renal Physiol, July 1, 2004; 287(1): F139 - F151. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gong, W. Wang, T.-H. Kwon, T. Jonassen, J. Frokiaer, and S. Nielsen Reduced renal expression of AQP2, p-AQP2 and AQP3 in haemorrhagic shock-induced acute renal failure Nephrol. Dial. Transplant., December 1, 2003; 18(12): 2551 - 2559. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |